SPONSOR
Huashan Hospital
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3
Conditions studied: Gastrointestinal TumorsGastric CancerHepatitis, ChronicEnd Stage Liver DIseaseComplicationImmunosenescenceRespiratory Infectious DiseasesCognitionHead and Neck Squamous Cell CarcinomaPatient Derived Organoid
Huashan Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Gastrointestinal Tumors, Gastric Cancer, Hepatitis, Chronic, End Stage Liver DIsease.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huashan Hospital
How many clinical trials has Huashan Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Huashan Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Gastrointestinal Tumors, Gastric Cancer, Hepatitis, Chronic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huashan Hospital research focus on?
Huashan Hospital clinical trials span Gastrointestinal Tumors, Gastric Cancer, Hepatitis, Chronic, End Stage Liver DIsease, Complication, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huashan Hospital clinical trial?
To participate in a Huashan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huashan Hospital trials with current recruitment status updated daily.
Clinical Trials by Huashan Hospital
NCT06775080 Phase 2
Recruiting
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Gastrointestinal Tumors
NCT06054906 Phase 2
Recruiting
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Gastric Cancer
NCT04025944
Recruiting
Real World Study of Chronic Viral Hepatitis
Hepatitis, Chronic
NCT04037995
Recruiting
Real World Study of End-stage Liver Disease in China
End Stage Liver DIsease
NCT07672522
Recruiting
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
Immunosenescence
NCT05965128
Recruiting
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
Respiratory Infectious Diseases
NCT06408415
Recruiting
A Study of the Higher Cognitive Functions of the Human Brain With Single-neuron Activity Recording
Cognition
NCT06686342
Recruiting
PDO Based Drug Sensitive Test in R/M HNSCC
Head and Neck Squamous Cell Carcinoma
NCT03649503
Recruiting
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Parkinsonian Disorders
NCT06022146 Phase 3
Recruiting
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Tuberculosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology